Patents by Inventor Stots B. REELE

Stots B. REELE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 18-MC FOR TREATMENT OF SUBSTANCE USE DISORDERS
    Publication number: 20230201217
    Abstract: A composition for treating substance use disorders of an effective amount of 18-Methoxycoronaridine salt (18-MC) in a pharmaceutical carrier. A method of treating substance use disorders, by administering an effective amount of 18-Methoxycoronaridine salt (18-MC) in a pharmaceutical carrier to an individual and preventing substance abuse in the individual. A method of preventing addictive behavior in an individual. A method of preventing craving in an individual. A composition of a metabolite of 18-MC salt. A method of treating substance use disorders by administering an effective amount of a metabolite of 18-MC salt in a pharmaceutical carrier to an individual and preventing substance abuse in the individual. A composition having various pharmacokinetic profiles as shown in the Figures.
    Type: Application
    Filed: February 24, 2023
    Publication date: June 29, 2023
    Applicant: Mind Medicine, Inc.
    Inventors: Scott FREEMAN, Stots B. REELE, Jeanne BONELLE
  • 18-MC for treatment of substance use disorders
    Patent number: 11596638
    Abstract: A composition for treating substance use disorders of an effective amount of 18-Methoxycoronaridine salt (18-MC) in a pharmaceutical carrier. A method of treating substance use disorders, by administering an effective amount of 18-Methoxycoronaridine salt (18-MC) in a pharmaceutical carrier to an individual and preventing substance abuse in the individual. A method of preventing addictive behavior in an individual. A method of preventing craving in an individual. A composition of a metabolite of 18-MC salt. A method of treating substance use disorders by administering an effective amount of a metabolite of 18-MC salt in a pharmaceutical carrier to an individual and preventing substance abuse in the individual. A composition having various pharmacokinetic profiles as shown in the Figures.
    Type: Grant
    Filed: October 1, 2020
    Date of Patent: March 7, 2023
    Assignee: Mind Medicine, Inc
    Inventors: Scott Freeman, Stots B. Reele, Jeanne Bonelle
  • 18-MC FOR TREATMENT OF SUBSTANCE USE DISORDERS
    Publication number: 20210093643
    Abstract: A composition for treating substance use disorders of an effective amount of 18-Methoxycoronaridine salt (18-MC) in a pharmaceutical carrier. A method of treating substance use disorders, by administering an effective amount of 18-Methoxycoronaridine salt (18-MC) in a pharmaceutical carrier to an individual and preventing substance abuse in the individual. A method of preventing addictive behavior in an individual. A method of preventing craving in an individual. A composition of a metabolite of 18-MC salt. A method of treating substance use disorders by administering an effective amount of a metabolite of 18-MC salt in a pharmaceutical carrier to an individual and preventing substance abuse in the individual. A composition having various pharmacokinetic profiles as shown in the Figures.
    Type: Application
    Filed: October 1, 2020
    Publication date: April 1, 2021
    Inventors: Scott FREEMAN, Stots B. REELE, Jeanne BONELLE